PedAM

Pediatric Disease Annotations & Medicines

Disease	narcolepsy
Symptom	C0694563\|excessive daytime sleepiness
Sentences	8
PubMedID- 20705253	The purpose of this study was to compare the objective multiple sleep latency test (mslt) and the subjective epworth sleepiness scale (ess) for evaluating the efficacy of modafinil in treating excessive daytime sleepiness in patients with narcolepsy in taiwan.
PubMedID- 22640618	Modafinil is a wake-promoting drug used for the treatment of excessive daytime sleepiness due to narcolepsy as well as excessive sleepiness associated with obstructive sleep apnea and shift work disorder.
PubMedID- 26474479	Nonetheless, the enhancement of histamine transmission obtained by antagonism of h3 inhibitory histamine auto-receptors limits the excessive daytime sleepiness associated with narcolepsy .
PubMedID- 24833927	Armodafinil is the pharmacologically active r-enantiomer of modafinil, a widely prescribed wake-promoting agent used to treat several sleep-related disorders including excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obstructive sleep apnea/hypopnea syndrome.
PubMedID- 23723550	Modafinil is a stimulant drug approved for the treatment of excessive daytime sleepiness associated with narcolepsy, shift-work sleep disorder, and obstructive sleep apnea syndrome by the us food and drug administration (fda).
PubMedID- 23470841	narcolepsy is a cause of excessive daytime sleepiness (eds) distinguished by abnormal intrusions of rapid eye movement (rem) sleep such as cataplexy, sleep paralysis, and hypnagogic hallucinations during wakefulness 1.
PubMedID- 22550980	This article gives an overview of sodium oxybate, which has been us fda approved for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy, and ema approved for the treatment of narcolepsy-cataplexy.
PubMedID- 22596015	Approximately 6 months later, narcolepsy-cataplexy with excessive daytime sleepiness occurred.

Page: 1